The objective of this study is to evaluate effectiveness and safety of Xience Sierra stent in the "real world" daily practice as compared with other drug-eluting stents.
Study Type
OBSERVATIONAL
Enrollment
2,000
Percutaneous coronary intervention with Xience Sierra stent
Dong-A Medical Center
Busan, South Korea
Inje University Busan Paik Hospital
Busan, South Korea
Gangwon National Univ. Hospital
Chuncheon, South Korea
Keimyung University Dongsan Medical Center
Composite event rate of death, non-fatal myocardial infarction (MI), or Target- Vessel Revascularization (TVR)
Time frame: 1 year
All cause death
Time frame: 5 year
Cardiac death
Time frame: 5 year
Myocardial Infarction
Time frame: 5 year
Composite event rate of death or myocardial infarction (MI)
Time frame: 5 year
Composite event rate of cardiac death or myocardial infarction (MI)
Time frame: 5 year
Target- Vessel Revascularization
Time frame: 5 year
Target- Lesion Revascularization
Time frame: 5 year
Stent thrombosis
Time frame: 5 year
Stroke
Time frame: 5 year
Procedural Success rate
Procedural success rate is defined as \< 30 % final stenosis and the absence of in-hospital event including death, myocardial infarction, repeat revascularization.
Time frame: 5 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Daegu, South Korea
Gangneung Asan Hospital
Gangneung, South Korea
Asan Medical Center
Seoul, South Korea
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Seoul, South Korea
The Catholic University of Korea, Yeouido St. Mary's Hospital
Seoul, South Korea
St.carollo Hospital
Suncheon, South Korea
Wonju Severance Christian Hospital
Wŏnju, South Korea